Chemical Business Newsbase articles from December 2005, page 5

Chemical Business Newsbase archives from December 2005

Astra Zeneca licence agreement with AtheroGenics.
December 22, 2005... (From Chemical Business NewsBase - Dagens Industri) Astra Zeneca has concluded a global licensing agreement with AtheroGenics Inc, US, for the pharmaceutical candidate AGI-1067 for the treatment of atherosclerosis. AtheroGenics will...

Investor Growth Capital become major shareholder in Doxa.
December 22, 2005... (From Chemical Business NewsBase - Dagens Industri) On 21 Dec 2005 approval was granted by shareholders of the Swedish biotechnology firm Doxa for Investor Growth Capital to acquire a new share issue, equivalent to 30% of Doxa's shares,...

European Commission fines members of rubber chemicals cartel.
December 22, 2005... (From Chemical Business NewsBase - Chemisch2Weekblad) The European Commission has imposed a fine of EUR 58.88 M on Bayer for playing a leading role in a cartel which between 1996 and 2001 made illegal price arrangements in the area of...

Biocomponent in Shell Euro petrol.
December 22, 2005... (From Chemical Business NewsBase - Chemisch2Weekblad) From 1 Jan 2006 Shell will begin adding ethyl tert-butyl ether (ETBE) to its Euro 95-petrol. Bioethanol is one of the raw materials for ETBE. Shell will therefore be the first oil...

Bengal likely to ban use of plastic bags.
December 22, 2005... (From Chemical Business NewsBase - Business Line) The West Bengal Government plans to ban the use of plastic bags in the State. The Government has urged business establishment to switch over to bio-degradable jute bags from...

Pfizer proposes new launches; separate divisions for therapeutic segments set up.
December 22, 2005... (From Chemical Business NewsBase - Business Line) Pharma major Pfizer Ltd, which introduced the product Viagra in India recently, plans to introduce more new products from its global portfolio and through product acquisitions. The...

JB Chemicals to set up Russian subsidiary.
December 22, 2005... (From Chemical Business NewsBase - Business Line) The Mumbai-based JB Chemicals & Pharmaceuticals Ltd (JB Chemicals) plans to set up a 100% subsidiary called OOO Unique Pharmaceuticals Laboratories in Moscow investing about $3 M. The...

Bird flu strain develops resistance to drug stockpiled by Britain.
December 22, 2005... (From Chemical Business NewsBase - The Independent) The only drug available against a threatened pandemic of avian flu may be useless for many of those infected and could make the pandemic worse, scientists fear. The warning came after a...

Dividend's in the bag at British Polythene.
December 22, 2005... (From Chemical Business NewsBase - The Independent) British Polythene Industries is Europe's largest manufacturer of plastic sacks and polythene film. The company, on 21 Dec 2005, put out a "reverse profits warning" which sent the shares...

Continuation of antidumping duty orders on granular polytetrafluoroethylene resin from Italy and Japan.
December 22, 2005... (From Chemical Business NewsBase - Federal Register) As a result of the determinations by the US Department of Commerce and the International Trade Commission that revocation of the antidumping duty orders on granular...

Antidumping duty order: superalloy degassed chromium from Japan.
December 22, 2005... (From Chemical Business NewsBase - Federal Register) Based on affirmative final determinations by the US Department of Commerce and International Trade Commission, the Department of Commerce is issuing an antidumping duty order on...

Phenylpropanolamine-containing drug products for over-the-counter human use: tentative final monographs.
December 22, 2005... (From Chemical Business NewsBase - Federal Register) The US Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking (notice) for over-the-counter (OTC) nasal decongestant and weight control drug products containing...

Titan buying top Indonesia's polyethylene producer.
December 22, 2005... (From Chemical Business NewsBase - The Star (Malaysia)) Titan Chemical Corp (Titan) plans to sign around $23-50 M agreement with PT Petrokimia Nusantara Interindo (PT) for acquiring the company. PT is Indonesia's largest polyethylene...

Poland: tender for chemical companies.
December 22, 2005... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Industrial holding PCC has acquired the exclusive negotiating rights for the Kedzierzyn and Tarnow chemical plants. It has thus for the moment beaten off Anwil, the...

EU imposes EUR 58.88 M cartel fine on Bayer.
December 22, 2005... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) The European Commission has decided Bayer must pay a fine of EUR 58.88 M for its part in a rubber chemicals cartel.

Philippines: government encourages use of alternative fuels.
December 22, 2005... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) In view of its considerable dependence on imports of oil and fuels, the Philippines government is looking to the use of alternative fuels from local sources. The focus is...

Linde acquires US speciality gases company Spectra Gases.
December 22, 2005... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Linde AG has acquired US speciality gases company Spectra Gases Inc from the Alvin family. The company has sales of EUR 50 M and employs 200.

Summa Industries announces 1Q 2005-2006 results. [3 tables].
December 22, 2005... (From Chemical Business NewsBase - Company Reports - CBNB) Summa Industries reported net income of $651,000 (net income of $610,000 in 1Q ended Nov 2004) on sales of $27.74 M for 1Q ended Nov 2005 ($25.488 M in 1Q ended Nov 2004). Three...

Price offered by Novartis for Chiron shares remains unchanged.
December 22, 2005... (From Chemical Business NewsBase - Neue Zuercher Zeitung) Swiss pharmaceuticals company Novartis in Basel will not increase the price for the takeover of the remaining shares in US vaccines manufacturer Chiron. The takeover bid for the...

Numico completes funding of EAC Nutrition takeover.
December 22, 2005... (From Chemical Business NewsBase - Het Financieele Dagblad) Numico has completed the arranged the funding of its takeover of EAC Nutrition for EUR 1.2 bn through a new EUR 482 M bank loan and the placement of a private loan in the US...

Shell sells activities in Uruguay, Paraguay, and Colombia.
December 22, 2005... (From Chemical Business NewsBase - Het Financieele Dagblad) Shell is selling all its downstream businesses in Paraguay and Uruguay plus certain of its assets in Colombia to Petroleo Brasileiro SA (Petrobras), presumably for $140 M. The...

Crucell licence agreement with SRC.
December 22, 2005... (From Chemical Business NewsBase - Het Financieele Dagblad) Crucell has entered into a PER.C6 licence agreement with the Saskatchewan Research Council (SRC) in Saskatoon, Canada. SRC will be allowed to sell services to PER.C6 licensees...

Crucell research and development agreement with WRAIR.
December 22, 2005... (From Chemical Business NewsBase - Het Financieele Dagblad) Crucell NV, Netherlands, and the Walter Reed Army Institute of Research (WRAIR) have entered into a Cooperative Research and Development Agreement (CRADA) for a study into how...

Crucell licence agreement with Merial.
December 22, 2005... (From Chemical Business NewsBase - Het Financieele Dagblad) Crucell NV has entered into a second PER.C6 licence agreement with Merial, a world leader in the area of veterinary vaccines. This non-exclusive contract will allow Merial to use...

Nuvo reports successful Pennsaid Phase III clinical trial results.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Nuvo Research Inc reported efficacy results from its preliminary analysis of the Phase III efficacy/safety trial for Pennsaid, designated 'Study 112'. The results have confirmed the...

Contract manufacturing agreement takes PER C6 into Canada.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Dutch biotechnology company Crucell NV has signed a PER C6 contract manufacturing licence agreement with the Saskatchewan Research Council (SRC) of Saskatoon, Canada. The agreement allows...

CytoGenix announces completion of synDNA production module prototype.
December 22, 2005... (From Chemical Business NewsBase - Press Release) CytoGenix Inc announced that the prototype version of the synDNA production module was completed on schedule. The device was designed specifically for the commercial production of...

Resverlogix Corp receives licence agreement term sheet for medical device ReVas programme.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Resverlogix Corp has received a term sheet for a Licence Agreement of its novel small molecule programme, ReVas, for the exclusive use in Drug Eluting Stents (DES) and medical devices....

Power3 files provisional patent application on surprising new discovery for neurodegenerative diagnostics; study reveals hitherto unknown differences in tagging of blood serum biomarkers between Parkinson's disease and ALS.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Power3 Medical Products Inc announced new and surprising results, revealing for the first time that 3 blood serum protein biomarkers useful in distinguishing patients with ALS (Lou...

Molecular changes its name to CytoCorp.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Molecular Diagnostics Inc is changing its name to CytoCorp Inc. The company's Board approved the name change during the recent Dec 2005 Board meeting. The company will be doing business as...

Scolr Pharma announces worldwide licensing agreement with Wyeth Consumer Healthcare.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Scolr Pharma Inc has executed a Licensing Agreement with Wyeth Consumer Healthcare, a division of Wyeth, granting Wyeth Consumer Healthcare the worldwide rights to utilize Scolr Pharma's...

Lannett Co receives approval for Baclofen tablets.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Lannett Co Inc has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Baclofen 20 mg tablets. According to NDC Health,...

New congressional defense bill supports development and purchase of vaccines to meet the nation's public health threats; Avant expects to participate in the development of new vaccine technologies to meet these threats.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Avant Immunotherapeutics Inc (Avant) announced that the new Congressional defense bill will provide over $3 bn for the development and purchase of vaccines, antivirals and necessary...

OSI Pharmaceuticals grants licence under dipeptidyl peptidase IV (DPIV) patents.
December 22, 2005... (From Chemical Business NewsBase - Press Release) OSI Pharmaceuticals Inc announced that its UK subsidiary focused on the discovery and development of diabetes and obesity therapeutics has granted a worldwide non-exclusive licence under...

ImClone Systems issues statement regarding Swissmedic approval of Erbitux for the treatment of head and neck cancer.
December 22, 2005... (From Chemical Business NewsBase - Press Release) ImClone Systems Inc issued the following statement regarding the approval by Swissmedic, the Swiss agency for therapeutic products, of Erbitux (cetuximab), an IgG1 monoclonal antibody, in...

Savient Pharmaceuticals requests two-week extension from NASDAQ regarding late filings; announces termination of prosaptide development programme.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Savient Pharmaceuticals Inc has requested that the Nasdaq Listing Qualifications Panel (the Panel) extend until 13 Jan 2006 the date by which the company must file amendments to its Form...

Kamada has completed the proof of feasibility phase for the manufacturing of its API prescription drug from the raw materials supplied by an Italian manufacturer.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Kamada has recently completed the proof of feasibility phase for an Italian company, towards the development of its API prescription drug manufactured with the Italian company's raw...

Sanofi-Aventis and Regeneron Pharmaceuticals expand their VEGF trap oncology collaboration to Japan.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Sanofi-aventis and Regeneron Pharmaceuticals Inc have amended their Vascular Endothelial Growth Factor (VEGF) Trap collaboration agreement to include Japan. The companies will now...

Medivir takes its first pharmaceutical project into Phase III and sharpens its strategic focus; labial herpes project ME-609 proceeds to Phase III with Medivir in control.
December 22, 2005... (From Chemical Business NewsBase - Press Release) The US Food and Drug Administration (FDA) in an End-of-Phase-II Meeting has recently approved Medivir's proposal for configuring the pivotal clinical trials to allow drug registration of...

Micrus Endovascular launches cerecyte 18 microcoil for treatment of large cerebral aneurysms.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Micrus Endovascular Corp announced the market launch of its 0.018-inch-diameter microcoil, Cerecyte 18, which expands the company's Cerecyte product line to include additional microcoils...

GreenShift's Mean Green Biofuels announces 30 M gallon biodiesel plant in north-eastern Indiana.
December 22, 2005... (From Chemical Business NewsBase - Press Release) GreenShift Corp portfolio company Mean Green BioFuels Corp (Mean Green) announced its plans to build a 30 M gallon/y biodiesel production facility in north-eastern Indiana. The new...

Acrongenomics Inc announces closing of $4,000,000 private placement to fund ongoing operations.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Acrongenomics Inc announced the closing of the 1,000,000 share private placement financing at $4.00/share as of 16 Dec 2005. Acrongenomics will use the net proceeds for the ongoing...

Callisto establishes guanilib as developmental name for novel drug candidate for GI disease; name established as company moves forward with first-in-class compound planned for clinical trial.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Callisto Pharmaceuticals Inc (Callisto) has established Guanilib as the developmental name for its proprietary drug candidate previously identified as SP304. Callisto scientists developed...

Exelixis and Wyeth sign licence agreement related to novel treatments for metabolic and liver diseases.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Exelixis Inc signed a licence agreement with Wyeth Pharmaceuticals, a division of Wyeth, related to compounds targeting the farnesoid X receptor, a nuclear hormone receptor implicated in a...

BioCryst Pharmaceuticals announces FDA approval to initiate human testing of intravenous peramivir.
December 22, 2005... (From Chemical Business NewsBase - Press Release) BioCryst Pharmaceuticals Inc announced that the US Food and Drug Administration (FDA) has given verbal approval to begin studies with intravenous peramivir, the company's influenza...

Pharmaceutical advertising: US vs Europe.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Pharmaceutical companies in Europe spend as much as 13% less on advertising than US companies, according to a recent study published by business intelligence leader Cutting Edge...

The Westaim Corp announces pricing for the initial public offering of its Nucryst Pharmaceuticals Corp subsidiary.
December 22, 2005... (From Chemical Business NewsBase - Press Release) The Westaim Corp announced the initial public offering of 4.5 M common shares of its subsidiary Nucryst Pharmaceuticals Corp (Nucryst) at a price of $10/share. The shares are being offered...

Osteotech receives FDA clearance for majority of its family of Grafton DBM products.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Osteotech Inc announced that the Food and Drug Administration (FDA) has cleared its 510(k) submission for the majority of its family of Grafton DBM products for use as a bone graft...

BioCryst Pharmaceuticals initiates intravenous Phase I/II clinical trial of Fodosine in patients with B-cell acute lymphoblastic leukaemia.
December 22, 2005... (From Chemical Business NewsBase - Press Release) BioCryst Pharmaceuticals Inc has initiated a Phase I/II clinical trial of Fodosine (forodesine hydrochloride), the company's lead anti-cancer compound, to determine the safety of repeat...

Voyager Pharmaceutical Corp announces progress in enrolment for Alzheimer's stud.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Voyager Pharmaceutical Corp announced its progress in enrolling subjects into the ALADDIN studies, Phase III double blind, placebo-controlled trial investigating the safety and efficacy of...

Cubist Pharmaceuticals reports results from Phase II study Hepex-B, which was licensed from XTLbio.
December 22, 2005... (From Chemical Business NewsBase - Press Release) XTL Biopharmaceuticals Ltd (XTLbio) announced that Cubist Pharmaceuticals Inc provided data from a recently concluded Phase II study of HepeX-B, which was licensed to Cubist...

Nanogen expands patent portfolio in genetic analysis technologies.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Nanogen Inc announced that its subsidiary Epoch Biosciences has been issued two patents by the US Patent and Trademark Office for technologies related to genetic analysis. The new patents...

Bristol-Myers Squibb statement on muraglitazar, an investigational oral treatment for Type II diabetes.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Bristol-Myers Squibb Co agreed to begin discussions with Merck & Co Inc to terminate the collaborative agreement for muraglitazar, the company's investigational oral medicine for the...

PTC Therapeutics initiates second Phase II study of PTC124 in patients with cystic fibrosis in Israel.
December 22, 2005... (From Chemical Business NewsBase - Press Release) PTC Therapeutics Inc (PTC) announced that the initiation of a Phase II study of PTC124 at Hadassah University Hospital in Israel in patients with cystic fibrosis (CF) due to a nonsense...

Schering-Plough announces Peg-Intron and Rebetol approved in Japan for expanded use in treating chronic hepatitis C.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Schering-Plough Corp announced that Schering-Plough KK, the company's country operations in Japan, has received marketing approval for a new, additional indication for Peg-Intron...

Procter & Gamble files infringement lawsuit.
December 22, 2005... (From Chemical Business NewsBase - Press Release) The Procter & Gamble Co has filed a lawsuit against McLane Co Inc, Salado Sales and Consumer Value Products Inc for trade dress infringement and unfair competition. The suit, filed in the...

Lilly to take asset impairment charges in 4Q 2005.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Eli Lilly and Co announced that, as part of the company's ongoing efforts to increase productivity and reduce its cost structure, it has finalized decisions that will result in charges in...

Abbott receives FDA approval for StarClose Vascular Closure System.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Abbott received Food and Drug Administration (FDA) approval to market its StarClose Vascular Closure System, a new vessel closure device engineered to enable faster, safe and secure...

Endo files responses to FDA's approvable letters on NDAs for oxymorphone ER and IR tablets.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Endo Pharmaceuticals Inc (Endo), a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc, has filed what it believes are complete responses to the US Food and Drug Administration's...

AtheroGenics and AstraZeneca announce late stage licence and commercialisation agreement for novel atherosclerosis drug AGI-1067.
December 22, 2005... (From Chemical Business NewsBase - Press Release) AtheroGenics Inc has entered into a licensing deal with AstraZeneca for the global development and commercialisation of their anti-inflammatory cardiovascular product candidate, AGI-1067....

Regeneration Technologies Inc announces first clinical implantation of xenograft implants.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Regeneration Technologies Inc (RTI) announced the first clinical implantations of its Sterling xenograft implants. Sterling interference screws have been recently implanted as tendon...

Shire announces filing of Mesavance (mesalamine) for treatment of ulcerative colitis.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Shire plc has submitted a New Drug Application (NDA) to the US Food and Drug Administration for Mesavance (SPD476), an investigational compound being studied for the induction of clinical...

Penwest announces that Endo reports filing of response to FDA'S approvable letter on NDA for oxymorphone ER tablets.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Penwest Pharmaceuticals Co (Penwest) announced that Endo Pharmaceuticals Inc (Endo), Penwest's partner in the development and commercialisation of oxymorphone extended-release tablets...

Alpharma declares regular quarterly cash dividend payable on 27 Jan 2006.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Alpharma Inc announced that its Board of Directors has declared a regular quarterly cash dividend of $0.045/common share. The dividend is payable 27 Jan 2006 to all shareholders on record...

Fitzsimons Redevelopment Authority welcomes DMI BioSciences as first tenant in bioscience east building at Fitzsimons.
December 22, 2005... (From Chemical Business NewsBase - Press Release) The Fitzsimons Redevelopment Authority (FRA) has signed a lease with DMI BioSciences (DMI), making it the first tenant of Bioscience East, a newly renovated 25,000 sq ft building in the...

EntreMed to acquire Miikana Therapeutics.
December 22, 2005... (From Chemical Business NewsBase - Press Release) EntreMed Inc has entered into a definitive merger agreement under which it will acquire all of the outstanding capital stock of Miikana Therapeutics Inc (Miikana) in exchange for 9.96 M...

Introgen updates regulatory guidance for Advexin therapy of head and neck cancer.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Introgen Therapeutics Inc (Introgen) announced its proposal to the US Food and Drug Administration (FDA) to request permission to accelerate the initiation of an interim analysis of its...

Wyeth submits New Drug Application for desvenlafaxine extended release (DVS-233) for depression.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Wyeth Pharmaceuticals has submitted a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for desvenlafaxine extended release (DVS-233) for the treatment of major...

Albemarle breaks ground for China Technology Center.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Albemarle Corp has begun site preparation for constructing a technology centre in China. Albemarle broke ground during third week of Dec 2005 at its site in Nanjing, China, where it will...

Anadys Pharmaceuticals to initiate 28-day clinical trial of ANA975 in patients with chronic hepatitis C.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Anadys Pharmaceuticals Inc plans to initiate a Phase Ib, placebo-controlled, multiple-dose clinical trial of ANA975 in chronic hepatitis C patients in Jan 2006. The trial is designed to...

Cephalon Inc completes acquisition of Zeneus Holdings Ltd.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Cephalon Inc has completed its previously announced acquisition of all of the outstanding share capital of Zeneus Holdings Ltd (Zeneus), a privately held company backed by funds advised by...

Par to acquire eight generic products.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Par Pharmaceutical Companies Inc (Par) has entered into agreements with Teva Pharmaceutical Industries Ltd, Ivax Corp and an affiliate of Teva to purchase for cash eight products that are...

Amylin Pharmaceuticals selects West Chester, OH, as the site for its $70 M biomedical manufacturing plant.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Butler County Board of Commissioners president Chuck Furmon announced that the Commissioners unanimously approved an eight-year, 75% Enterprise Zone tax abatement for Amylin Ohio LLC, a...

Carrington reaches agreement to settle litigation.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Carrington Laboratories Inc (Carrington) has reached an agreement to settle the litigation brought by Swiss-American Products Inc, a private label manufacturer. Under the terms of the...

Cephalon Inc announces agreement with Ranbaxy Laboratories Ltd regarding settlement of Provigil patent litigation.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Cephalon Inc has entered into an agreement with Ranbaxy Laboratories Ltd (Ranbaxy) to settle its pending patent infringement dispute in the US related to Provigil (modafinil) Tablets...

Neose provides update on NE-180 programme.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Neose Technologies Inc (Neose) provided an update on its NE-180 (GlycoPEG-EPO) programme. The company has been pursuing parallel efforts in the US and Europe to move its NE-180 candidate...

Dow AgroSciences announces research collaboration with University of Melbourne to pursue plant-made vaccine solution to Avian Influenza.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Dow AgroSciences LLC has been named as the industry partner with the University of Melbourne in a Linkage Grant from the Australian Research Council to pursue development of plant-made...

Voyager begins Alzheimer's disease medication studies.
December 22, 2005... (From Chemical Business NewsBase - Press Release) Voyager Pharmaceutical Corp, Raleigh, NC, is enrolling people in a Phase III clinical study to determine the effectiveness of VP4896, a compound designed to treat mild-to-moderate...

Adherex wins orphan status for lead drug.
December 21, 2005... (From Chemical Business NewsBase - Press Release) The US Food and Drug Administration granted orphan status to Adherex, Durham, NC, for the development of the company's lead drug, Eniluracil. The drug is designed to work with...

Aradigm completes manufacture of Intraject Sumatriptan pivotal stability lots.
December 21, 2005... (From Chemical Business NewsBase - Press Release) Aradigm Corp announced the completion of manufacturing of pivotal and clinical batches of its Intraject Sumatriptan product on its commercial-scale manufacturing line. With the successful...

Regulatory authority's notification shortens preparation period for dSLIM clinical studies.
December 21, 2005... (From Chemical Business NewsBase - Press Release) Mologen AG has received a confirmation from the responsible regulatory authority, that the production of DNA based immunomodulator dSLIM does not require a manufacturing authorisation...

Crucell and DSM announce second PER.C6 licence agreement with Ferring Pharmaceuticals.
December 21, 2005... (From Chemical Business NewsBase - Press Release) Crucell NV and allied contract manufacturer DSM Biologics have signed a second PER.C6 commercial licence agreement with Ferring Pharmaceuticals (Ferring). This licence agreement allows...

Theravance and Astellas report results from pre-clinical studies with investigational antibiotic Telavancin.
December 21, 2005... (From Chemical Business NewsBase - Press Release) Theravance Inc announced that results of pre-clinical studies with telavancin were presented at the 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)...

SciClone reports results from Zadaxin proof-of-concept liver cancer trial.
December 21, 2005... (From Chemical Business NewsBase - Press Release) SciClone Pharmaceuticals (SciClone) reported data from its small, Phase II proof-of-concept hepatocellular carcinoma (liver cancer) trial indicating a trend towards positive survival...